A controlled trial of natalizumab for relapsing multiple sclerosis. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GPA, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW, et al. N Engl J Med. 2003 Jan 2; 348(1):15-23. PMID: 12510038. Abstract CommentRecommendBookmarkWatch